Quadrant Capital Group LLC Cure Vac N.V. Transaction History

Quadrant Capital Group LLC

$3 Billion
Q3 2025

A detailed history of Quadrant Capital Group LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 40,854 shares of CVAC stock, worth $215,709. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,854

Previous 39,311 3.93%

Holding current value

$215,709

Previous $213,000 3.29%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$5.34 - $5.51 $8,239 - $8,501	1,543 Added 3.93%	40,854 $220,000
Q2 2025 Aug 12, 2025	SELL	$2.59 - $5.6 $14,724 - $31,835	-5,685 Reduced 12.63%	39,311 $213,000
Q1 2025 May 13, 2025	SELL	$2.77 - $4.68 $13,905 - $23,493	-5,020 Reduced 10.04%	44,996 $124,000
Q4 2024 Feb 12, 2025	BUY	$2.49 - $3.41 $47,554 - $65,124	19,098 Added 61.77%	50,016 $170,000
Q3 2024 Nov 12, 2024	SELL	$2.74 - $3.79 $8,658 - $11,976	-3,160 Reduced 9.27%	30,918 $90,000

Q2 2024 Aug 12, 2024	BUY	$2.31 - $4.99 $35,322 - $76,302	15,291 Added 81.39%	34,078 $115,000
Q1 2024 May 15, 2024	BUY	$2.94 - $4.34 $49,624 - $73,254	16,879 Added 884.64%	18,787 $56,000
Q4 2023 Feb 08, 2024	BUY	$3.96 - $6.41 $4,490 - $7,268	1,134 Added 146.51%	1,908 $8,000
Q3 2023 Nov 14, 2023	SELL	$6.5 - $10.77 $5,206 - $8,626	-801 Reduced 50.86%	774 $5,000
Q2 2023 Aug 09, 2023	BUY	$6.69 - $12.25 $5,385 - $9,861	805 Added 104.55%	1,575 $16,000
Q1 2023 May 11, 2023	BUY	$6.38 - $12.5 $2,284 - $4,475	358 Added 86.89%	770 $5,000
Q4 2022 Feb 10, 2023	SELL	$5.75 - $8.5 $5,623 - $8,313	-978 Reduced 70.36%	412 $2,000
Q3 2022 Nov 10, 2022	SELL	$7.48 - $15.24 $17,794 - $36,255	-2,379 Reduced 63.12%	1,390 $11,000
Q2 2022 Aug 09, 2022	BUY	$13.18 - $19.41 $11,044 - $16,265	838 Added 28.59%	3,769 $51,000
Q1 2022 May 06, 2022	BUY	$14.73 - $35.25 $23,170 - $55,448	1,573 Added 115.83%	2,931 $57,000
Q4 2021 Feb 01, 2022	BUY	$33.72 - $48.22 $45,488 - $65,048	1,349 Added 14988.89%	1,358 $47,000
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $443 - $670	9 New	9 $0

Others Institutions Holding CVAC

# of Institutions

108

Shares Held

22.5M

Call Options Held

124K

Put Options Held

77.1K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $990M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Cure Vac N.V. Transaction History